A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells-Reference-Cited by-同舟云学术

A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells

Published:2021-04-26 Issue: Volume: Page:
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Kim Yoo Chun,Hsueh Henry T.,Shin Matthew D.,Berlinicke Cynthia A.,Han Hyounkoo,Anders Nicole M.,Hemingway Avelina,Leo Kirby T.,Chou Renee Ti,Kwon HyeYoung,Appell Matthew B.,Rai Usha,Kolodziejski Patricia,Eberhart Charles,Pitha Ian,Zack Donald J.,Hanes Justin,Ensign Laura M.^ORCID

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s13346-021-00987-6.pdf

Reference62 articles.

1. Atey TM, et al. The impact of adherence and instillation proficiency of topical glaucoma medications on intraocular pressure. J Ophthalmol. 2017;2017:1683430.

2. Rodrigues GA, et al. Topical drug delivery to the posterior segment of the eye: addressing the challenge of preclinical to clinical translation. Pharm Res. 2018;35(12):245.

3. Kim YC, et al. Gelling hypotonic polymer solution for extended topical drug delivery to the eye. Nat Biomed Eng. 2020;4(11):1053–62.